Cited by 21Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Killing pain?: a population-based registry study of the use of prescription analgesics, anxiolytics, and hypnotics among all children, adolescents and young adults in Norway from 2004 to 2019

Open access
Stangeland, Helle, Handal, Marte, Skurtveit, Svetlana Ondrasova, Aakvaag, Helene Flood, Dyb, Grete, Wentzel-Larsen, Tore, Baumann-Larsen, Monica, Zwart, John Anker +2 more·2023·European Child & Adolescent Psychiatry

Abstract

The ongoing opioid epidemic has been a global concern for years, increasingly due to its heavy toll on young people's lives and prospects. Few studies have investigated trends in use of the wider range of drugs prescribed to alleviate pain, psychological distress and insomnia in children, adolescents and young adults. Our aim was to study dispensation as a proxy for use of prescription analgesics, anxiolytics and hypnotics across age groups (0-29 years) and sex over the last 15 years in a large, representative general population. The study used data from a nationwide prescription database, which included information on all drugs dispensed from any pharmacy in Norway from 2004 through 2019. Age-specific trends revealed that the prevalence of use among children and adolescents up to age 14 was consistently low, with the exception of a substantial increase in use of melatonin from age 5. From age 15-29, adolescents and young adults used more prescription drugs with increasing age at all time points, especially analgesics and drugs with higher potential for misuse. Time trends also revealed that children from age 5 were increasingly dispensed melatonin over time, while adolescents from age 15 were increasingly dispensed analgesics, including opioids, gabapentinoids and paracetamol. In contrast, use of benzodiazepines and z-hypnotics slightly declined in young adults over time. Although trends were similar for both sexes, females used more prescription drugs than their male peers overall. The upsurge in use of prescription analgesics, anxiolytics and hypnotics among young people is alarming.Trial registration The study is part of the overarching Killing Pain project. The rationale behind the Killing Pain research was pre-registered through ClinicalTrials.gov on April 7, 2020. Registration number NCT04336605; https://clinicaltrials.gov/ct2/show/record/NCT04336605 .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00787-022-02066-8

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individuals suffering from chronic pain are at increased risk for the use and potential misuse of hypnotics to alleviate pain-induced insomnia.

    “Individuals suffering from chronic pain are at increased risk for the use—and potential misuse—of hypnotics to alleviate pain-induced insomnia.”

    From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [53]

    The Introduction describes pain and insomnia as often co-occurring concerns among young people and identifies z-hypnotics as drugs with misuse potential. The Discussion mentions hypnotic treatment for insomnia. Neither section establishes that people with chronic pain have an increased risk of using or misusing hypnotics, or that their insomnia is pain-induced. (LLM, conf=0.81)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 47 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. [2]Bachman JG Schulenberg JE Freedman-Doan P O'Malley PM Johnston LD Messersmith EE The education-drug use connection: How successes and failures in school relate to adolescent smoking, drinking, drug use, and delinquency 2008 London Psychology Press
  2. [32]National Institute for Health and Care Excellence Management of generalised anxiety disorder in adults 2011 London NICE 31961629
  3. [58]World Health Organization (2020) Guidelines on the management of chronic pain in children. In: WHO 33433967

Cited by

Sorted by citations

Authors
Stangeland, H., Handal, M., Skurtveit, S. O., Aakvaag, H. F., Dyb, G., Wentzel-Larsen, T., Baumann-Larsen, M., Zwart, J. A., Storheim, K., & Stensland, S. Ø.
Affiliations
  • Oslo University Hospital (NO)
  • Norwegian Institute of Public Health (NO)
  • Norwegian Centre for Violence and Traumatic Stress Studies (NO)
  • University of Oslo (NO)
Corresponding author
Stangeland, Helle
Venue
European Child & Adolescent Psychiatry
Published
2022-08-27
Volume
32
Issue
11
Pages
2259-2270
ISSN
  • 1018-8827 (ISSN-L)
  • 1435-165X
OpenAlex
W4293348902
Cited by
21
References
47
Citations by year
2026: 5 · 2025: 9 · 2024: 2 · 2023: 5
FWCI
3.53
Type
journal article
Language
en
Open access
Locations
  • European Child & Adolescent Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
  • Dam Foundation (2020/FO283043)
  • University of Oslo
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
prescription analgesics, anxiolytics, hypnotics, opioid epidemic, children, adolescents, young adults, melatonin, benzodiazepines, gabapentinoids, paracetamol, sex differences in drug use
MeSH terms
Adolescent, Adult, Analgesics, Analgesics, Opioid, Child, Child, Preschool, Female, Humans, Hypnotics and Sedatives, Infant, Infant, Newborn, Male, Melatonin, Norway, Pain, Drug Prescriptions, Registries, Anti-Anxiety Agents, Prescription Drugs, Prescriptions, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review